Speakers

Pibarot, Philippe

Philippe Pibarot obtained a doctorate in veterinary medicine (DVM) in 1987 at the University Claude Bernard in Lyon, France and a PhD degree in biomedical sciences from the University of Montreal in April 1995. He has received the FACC, FAHA, FASE, FESC, FASE, FCCS credentials. He is full professor at the Department of Medicine of Laval University and he holds the Canada Research Chair (Level I) in Valvular Heart Disease (VHD) at the Québec Heart & Lung Institute. He is the head of Cardiology Research at Québec Heart & Lung Institute.

The objective of his research program is to develop and validate novel patient-oriented approaches to improve the diagnosis, prevention, and treatment of VHD. He is currently the principal investigator of several multicenter studies and trials funded by Canadian Institutes of Health Research through a 7-year Foundation grant. He is director of the Echocardiography Core Laboratory at the Québec Heart & Lung Institute. He has published more than 650 articles and presented >900 invited conferences in the course of his career. He is associate editor for Structural Heart and Eurointervention journals and Imaging section editor for the Journal of the American College of Cardiology. He received the Annual Achievement Award of the Canadian Society of Echocardiography (2010), the Research Achievement Award, Canadian Cardiovascular Society (2010), and the Feigenbaum Lecture Award, American Society of Echocardiography (2012), and a Doctorate Honoris Causa of University of Liège, Belgium (2017). He is an ex-officio member of the nucleus of the Council in Valvular heart Diseases of the European Society of Cardiology. He is a founding member of Heart Valve Voice Canada. He is a member of the Steering Committees of the Rb-ARMI, MITNEC, and PARTNER I & II, TAVR-UNLOAD, and EARLY-TAVR clinical trials. He is among the most influential scientists in the field of Medicine according to the Clarivate Analytics Highly Cited Researchers 2018, 2019, and 2020.